13F

Stock

Enanta Pharmaceuticals Inc

ENTA · held by 3 managers

Reported value

$566.2K

Holders

3

+1 new · −0 exited

Holders’ est. mark

$72.2K

Price effect on 1 books still in the name

Largest holder

$362K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC47.9K$362K$72.2KAdded$166.7K
Sanctuary Advisors, LLC25.4K$192.2KNew
Essential Partners LLC1.57K$11.9KHeld

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.